Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...
5hon MSNOpinion
Especially if they come with reductions to Medicaid, food stamps and other safety net programs, the policy will make the rich ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback